Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparing of a 22G EUS Procore Fine Needle Biopsy Device and a 20G EUS Procore Fine Needle Biopsy Device for Solid Pancreatic Lesions: a Prospective Multi-center, Randomized, and Controlled Trial

NCT03803930 is registered in ClinicalTrials.gov with Huazhong University of Science and Technology as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03803930 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparing of a 22G EUS Procore Fine Needle Biopsy Device and a 20G EUS Procore Fine Needle Biopsy Device for Solid Pancreatic Lesions: a Prospective Multi-center, Randomized, and Controlled Trial
Lead sponsor
Huazhong University of Science and Technology
Phase
Not applicable
Overall status
Unknown status
Start date
March 1, 2019
Completion date
August 1, 2020
Enrollment
1,224 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pancreas neoplasms